OpenAI acquires Orchestra Bio
OpenAI News · 2026-10-20
OpenAI is acquiring Orchestra Bio to bring AI-powered operations to life sciences R&D, helping biopharma teams accelerate drug development and advance new treatments.
Read the original at OpenAI News
More AI news
- Making the internet better for AI agents might make it worse for everyone else
- Run your n8n AI workflows on NVIDIA DGX Spark, with no cloud API
- Advancing coding in low‑resource programming languages
- AI researchers stranded Claude on a virtual desert island. It started to “play.”
- API documentation: What it is and how to write it (with examples)